Central Garden & Pet CoCENTA

Central Garden & Pet, the California-based pet and garden products group, posted $906.2 million of revenue in its quarter to March 2026, up from $3.13 billion in the prior full-year filing for the twelve months to September 2025, while net income attributable to the parent came in at $79.4 million for the same quarter. The company’s operating income stood at $113.9 million, but operating cash flow swung to negative $119.9 million in the quarter, and free cash flow-after $21.3 million of capex-was materially negative. Cash and equivalents remained healthy at $653.2 million, yet the balance sheet also shows inventories up $59.3 million to $782.3 million, a number that invites questions about stock turns and working-capital discipline.

Central Garden & Pet sells branded pet products (Dog & Cat and Animal Health) and garden products (seed, tools, soils, and outdoor living lines) through mass retailers, pet superstores, and e-commerce. The group’s scale and multi-channel reach make it a fixture on garden-centre forecourts and pet-aisle end-caps across North America. Revenue growth has been driven by pet lines, with dog and cat products alone adding $29.1 million in the quarter versus a year ago, while garden lines added $46.3 million. The company also distributes third-party brands, though sales of those dropped modestly in pet and rose modestly in garden.

For the quarter to March 2026, Central Garden & Pet reported revenue excluding tax of $906.2 million, a net income attributable to the parent of $79.4 million, operating income of $113.9 million, and diluted earnings per share of $1.28 on 61.9 million diluted shares. Stockholders’ equity stood at $1.65 billion, total assets at $3.75 billion, and cash and cash equivalents at $653.2 million. Net cash used in operating activities was negative $119.9 million; capex was $21.3 million; and inventories rose by $59.3 million to $782.3 million. The company’s 11-K filing notes that executive share sales under 10b5-1 plans are priced using the average of the daily high and low on specified market days, a process the filings describe as routine and compliant.

The group’s latest investor materials trumpet a “strategic pet distribution joint venture” with Phillips Pet Food & Supplies, but the filing trail stops at the press release promise rather than the joint-venture contract itself. The company’s own filings do not quantify the venture’s size, timing, or impact on margins, leaving investors to take the announcement on trust until further disclosure arrives. The 10-Q cautions that inventory levels remain elevated and that cash flow from operations turned negative in the recent quarter, two facts that sit uneasily beside the glossy headlines.

For context, the company’s SEC filings and press-releases rail is the only public source we can cite today; no analyst consensus, valuation commentary, or chart levels are supplied by the evidence set. If the next quarterly filing includes segment-level margin bridges, working-capital detail, or a quantification of the Phillips joint venture, we will update accordingly. Until then, the garden looks colourful but the cashflow soil is still drying out.